Contacts, documents and full notice history are available with a subscription.
Special Notice NONE Expired 1 notice 1 document

Transcranial Magnetic Stimulation (TMS) Chair HT942525CC0216

Solicitation HT942525CC0216 Copied Notice ID 47b436a7ef954098b1fe271200c59a1e Copied DEPT OF DEFENSE — ARMY MED RES ACQ ACTIVITY
SAM.gov
Posted
Aug 08, 2025
Deadline
Aug 24, 2025
Set-aside
NONE
NAICS
334516
PSC
6640

Summary

AI-generated · Aug 24, 2025

Procure one Transcranial Magnetic Stimulation (TMS) chair for use at Naval Medical Center San Diego. The system must be FDA-cleared for Major Depressive Disorder and obsessive-compulsive disorder, align with DHA behavioral health protocols, and provide secure documentation and treatment traceability compliant with HIPAA and DoD patient care standards.

Magstim Inc. is identified as the sole supplier capable of delivering a system meeting the Government’s clinical and operational requirements, including the FDA-approved 3D neuronavigation system (StimGuide) with integrated EMG for precise coil placement. The unit delivers up to 40 million pulses per device, offering lower lifecycle costs. The award will be a firm-fixed-price contract under a sole-source process; responses will be considered to assess whether a competitive procurement is in the Government’s best interest, and if no written responses are received, the award will proceed as sole source.

This notice announces the intent by the U.S. Army Medical Acquisition Activity (USAMRAA), Fort Detrick, Maryland, 21702, to award a sole source Firm-Fixed-Price (FFP) Contract to Magstim Inc., under the statutory authority 13.501(a). The contract is for the purchase of one Transcranial Magnetic Stimulation (TMS) chair at the Naval Medical Center San Diego (NMCSD). Market research has determined that Magstim Inc. is the sole provider capable of delivering the Transcranial Magnetic Stimulation (TMS) system that meets the Government s specific clinical and operational requirements. The selected TMS machine is FDA-cleared for the treatment of resistant depression and incorporates proprietary technology that aligns with DHA behavioral health protocols and prior clinical use at other military treatment facilities. This system is FDA-cleared for Major Depressive Disorder and OCD, meeting DoD standards for TMS treatment delivery in military settings. Additionally, it supports secure documentation and treatment traceability, ensuring compliance with HIPAA and DoD patient care standards. Magstim is the only TMS provider offering an FDA-approved 3D neuronavigational system (StimGuide) with integrated EMG functionality, ensuring 100% accurate coil placement and superior precision. The system delivers up to 40 million pulses per device double the capacity of most competitors, which typically offer 20 million pulses. This increased capacity translates to a lower cost of ownership over the device s lifecycle, maximizing long-term value and reducing operational overhead. Delivery Date: 30 September 2025 The North American Industry Classification System (NAICS) for this requirement is 334516 and the size standard is 1,000. This announcement fulfills the synopsis requirements under FAR 5.102(a)(6) and 5.203(a). USAMRAA intends to award a contract no sooner than 15 days after publishing this synopsis. This Special Request for Information is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the expiration date listed in this notice, which reflects at least fifteen (15) days after the publication of this notice, the award will be issued as sole source. All questions and responses concerning this notice shall be emailed to Mr. Christopher L. Cook at christopher.l.cook68.civ@health.mil.

From Special Notice posted on Aug 08, 2025

Notice history

1
  1. Special Notice LATEST Posted Aug 08, 2025

Details

Solicitation number HT942525CC0216
Notice ID 47b436a7ef954098b1fe271200c59a1e
Notice type Special Notice
Product / Service (PSC) 6640
NAICS 334516
Set-aside No Set aside used
Place of performance Frederick, Maryland
Archive date Sep 08, 2025

Award Information

Not yet awarded

Documents

1
View on SAM.gov

Contacts

primary
Christopher Cook

Email

Phone

Agency

DEPT OF DEFENSE
DEFENSE HEALTH AGENCY (DHA)
ARMY MED RES ACQ ACTIVITY

Place of Performance

Frederick, Maryland 21702
USA

Dates

Posted Aug 08, 2025 1 year ago
Last Updated Aug 06, 2026 2 days ago
Due Aug 24, 2025 11 months ago